Sarkar Shubho R, Wystrychowski Grzegorz, Zhu Fansan, Usvyat Len A, Kotanko Peter, Levin Nathan W
Weill Cornell Medical Center, New York-Presbyterian Hospital, New York, NY, USA.
ASAIO J. 2007 May-Jun;53(3):339-42. doi: 10.1097/MAT.0b013e318033cba7.
Fluid shifts during hemodialysis involve changes in both extracellular and intracellular volumes. This study aimed to determine the effect of intradialytic sodium gradients (GNa), that is, the difference between dialysate and serum sodium concentration, on dynamics of extracellular and intracellular volumes in a group of maintenance hemodialysis patients. Extracellular volume change (deltaECV) between predialysis and postdialysis periods was determined by whole-body bioimpedance spectroscopy; intracellular volume change (deltaICV) was indirectly derived as the difference between deltaECV and the change in body weight, corrected for intradialytically given fluids. A total of 200 bioimpedance measurements were performed in 32 dialysis patients. Extracellular and intracellular volume changes were -2.6 +/- 0.9 L (range: -4.7 to -0.5 L) and -0.2 +/- 0.7 L (range: -2.5 to +1.5 L), respectively. There was a significant correlation between deltaICV and GNa; deltaICV = -0.12 * GNa + 0.26 (p < 0.001). In contrast, GNa was not correlated with deltaECV. We conclude that the sodium gradient between dialysate and plasma has a significant effect on the ICV during dialysis. Hemodialysis with GNa = 0 mmol/L should be sought to prevent ICV shrinking or swelling and to prevent excessive thirst, consequently high interdialytic weight gains, and ultrafiltration rates.
血液透析过程中的液体转移涉及细胞外液和细胞内液容量的变化。本研究旨在确定透析期间钠梯度(GNa),即透析液与血清钠浓度之间的差异,对一组维持性血液透析患者细胞外液和细胞内液容量动态变化的影响。通过全身生物电阻抗光谱法测定透析前和透析后期间的细胞外液容量变化(deltaECV);细胞内液容量变化(deltaICV)通过deltaECV与体重变化之间的差值间接得出,并对透析期间给予的液体进行校正。对32例透析患者共进行了200次生物电阻抗测量。细胞外液和细胞内液容量变化分别为-2.6±0.9L(范围:-4.7至-0.5L)和-0.2±0.7L(范围:-2.5至+1.5L)。deltaICV与GNa之间存在显著相关性;deltaICV = -0.12 * GNa + 0.26(p < 0.001)。相比之下,GNa与deltaECV无相关性。我们得出结论,透析液与血浆之间的钠梯度对透析期间的ICV有显著影响。应寻求GNa = 0 mmol/L的血液透析,以防止ICV缩小或肿胀,并防止过度口渴,从而避免透析间期体重过度增加和超滤率过高。